Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Metabolic medicine

Looking Ahead: Development and Brain Health

At a Glance

Early treatment helps many children with MSUD reach a normal IQ range, but specific challenges with development, attention, learning, mental health, or brain health can still occur. Ongoing monitoring and family support help identify needs early.

While early diagnosis through newborn screening has transformed the lives of children with Maple Syrup Urine Disease (MSUD), the condition still presents lifelong challenges for brain health and development [1]. Even with excellent dietary management, the brain remains sensitive to both sudden spikes in leucine and the long-term effects of the disease [2].

Developmental Patterns in Childhood

Most children with MSUD who are treated early achieve an IQ in the normal range, but “total IQ” scores do not always tell the whole story [3]. Many children show variable executive, attention, processing-speed, visuospatial, and language profiles, where their verbal skills (speaking, vocabulary) are much stronger than their “performance” skills (problem-solving, puzzles, visuospatial tasks) [3][P-230].

  • Executive Dysfunction: This pattern often points to challenges with executive function—the brain’s “air traffic control” system that manages attention, planning, and memory [3]. Routine developmental surveillance is essential, with referral to speech, occupational, or physical therapy when indicated.
  • Physical Milestones: Delays in walking, sentence formation, and toilet training can occur. In one small study of 13 children, largely with the classic subtype, delays in walking (85%), sentence formation (92%), and toilet training (92%) were reported [4]. These findings highlight the need for early support, though individual trajectories vary widely.
  • School Support: Because of these specific cognitive patterns, it is vital to have neuropsychological testing performed, especially at school transitions. These evaluations go deeper than standard school tests and can help you secure an Individualized Education Program (IEP) or 504 plan (in the U.S., or local equivalents elsewhere) to support your child’s unique learning needs, such as extended test time or visual aids [3][P-230].

Psychiatric Risks and the Brain

As children with MSUD move into adolescence and adulthood, they face a higher risk of psychiatric conditions. These are not just “emotional reactions” to a difficult diet; they are often linked to how the disease affects brain chemistry [5].

  • Common Conditions: Research shows that adults in specific MSUD cohorts often require psychiatric or psychological care for anxiety, depression, or ADHD [6][5]. Ongoing anxiety or depression deserves dedicated mental-health evaluation.
  • The Risk of Psychosis: In cases of metabolic crisis where leucine levels become very high, some patients experience acute psychosis (hallucinations, delusions, or severe behavior change) [7][8]. Interestingly, these symptoms often disappear rapidly once the leucine levels are brought back into a safe range, suggesting a strong association between metabolism and mental health [7]. However, any sudden confusion, hallucinations, inability to stay awake, or unsafe behavior requires urgent medical assessment by the metabolic team or emergency services.
  • The Physical Impact: During a crisis, high leucine can cause cytotoxic edema—a form of brain swelling where water enters the brain cells [9]. On an MRI, this looks like “restricted diffusion” in specific areas of the brain [10]. While these changes can improve after treatment, repeated or severe crises may leave permanent marks on the brain’s white matter [4][11].

Quality of Life and the Family Burden

MSUD is a family diagnosis. The constant vigilance required for dietary management and the fear of a metabolic crisis can create a significant burden on parents and caregivers [12].

  • Social and Emotional Impact: Younger children often struggle with the social stigma of a restricted diet, especially at parties or school events, while older children and teens may experience fatigue and concerns about their independence [12].
  • Shared Responsibility: Studies show that families with strong support systems often have children with fewer metabolic crises [6]. This should be a shared responsibility among caregivers, the metabolic team, school, and support services—do not carry it all alone.
  • Transitioning Care: As your child reaches adulthood, the transition from a pediatric team to an adult metabolic specialist is a critical time [6]. Planning for this early ensures that your child continues to receive the specialized monitoring they need to maintain their mental and physical health [13].

You are not alone in this journey. Connecting with other families through MSUD support organizations can provide practical advice and emotional strength that even the best medical team cannot offer [12].

Common questions in this guide

Can children with MSUD have typical IQ scores?
Many children who receive early treatment have an IQ in the normal range. However, a total IQ score may not show differences in attention, planning, processing speed, visual-spatial skills, or language, so a child may still need tailored support.
What developmental changes should families watch for in MSUD?
Some children may have delays in walking, forming sentences, or toilet training, and others may have difficulty with attention, planning, memory, or processing speed. Regular developmental checks can identify needs early and may lead to speech, occupational, or physical therapy.
Why might my child need neuropsychological testing?
This testing looks more closely than routine school tests at attention, planning, memory, processing speed, language, and visual-spatial skills. Results can guide classroom supports such as an Individualized Education Program (IEP), a 504 plan, extended test time, or visual aids.
What mental-health problems can MSUD be associated with?
People with MSUD may need evaluation or care for anxiety, depression, or ADHD. Very high leucine during a metabolic crisis can also be associated with sudden psychosis, including hallucinations, delusions, or severe behavior changes, so both metabolic and mental-health causes need attention.
Which changes during an MSUD crisis require urgent medical help?
Sudden confusion, hallucinations, inability to stay awake, or unsafe behavior can signal a serious problem and require urgent assessment. Contact the metabolic team immediately or use emergency services, especially when these changes occur during a suspected metabolic crisis.
Can MSUD crises cause lasting brain changes?
High leucine during a crisis can cause brain swelling, and MRI changes may improve after treatment. Repeated or severe crises may still leave lasting changes in the brain’s white matter, so preventing crises and following the metabolic plan are important.
How can families prepare for adulthood with MSUD?
Start planning the move from pediatric care to an adult metabolic specialist before the transition occurs. Keeping caregivers, the metabolic team, school, and support services involved can help maintain monitoring, while MSUD support organizations may offer practical and emotional help.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How does my child's history of peak leucine levels and metabolic crises influence their developmental outlook?
  2. 2.What are the specific signs of executive dysfunction, attention issues, or processing speed delays we should watch for?
  3. 3.When should we schedule a formal neuropsychological evaluation to help secure educational accommodations?
  4. 4.If my child shows signs of anxiety or ADHD, how do we evaluate them for both psychiatric needs and metabolic stability?
  5. 5.What resources are available to help our family transition care to an adult metabolic specialist in the future?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    Impact of early diagnosis, disease variant, and quality of care on the neurocognitive outcome in maple syrup urine disease: A meta-analysis.

    Scharre S, Mengler K, Schnabel E, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2025; (27(1)):101303 doi:10.1016/j.gim.2024.101303.

    PMID: 39431354
  2. 2

    Treatment Outcomes for Maple Syrup Urine Disease Detected by Newborn Screening.

    Mengler K, Garbade SF, Gleich F, et al.

    Pediatrics 2024; (154(2)) doi:10.1542/peds.2023-064370.

    PMID: 38957900
  3. 3

    Neurocognitive profiles in MSUD school-age patients.

    Bouchereau J, Leduc-Leballeur J, Pichard S, et al.

    Journal of inherited metabolic disease 2017; (40(3)):377-383 doi:10.1007/s10545-017-0033-7.

    PMID: 28324240
  4. 4

    Treatment strategies, radiological recovery, and neurodevelopmental outcomes in paediatric Maple Syrup Urine Disease: a 20-year single-centre experience from Türkiye.

    Uylaş K, Yazıcı H, Altınok YA, et al.

    Metabolic brain disease 2026; (41(1)).

    PMID: 42329506
  5. 5

    Brain Branched-Chain Amino Acids in Maple Syrup Urine Disease: Implications for Neurological Disorders.

    Xu J, Jakher Y, Ahrens-Nicklas RC

    International journal of molecular sciences 2020; (21(20)) doi:10.3390/ijms21207490.

    PMID: 33050626
  6. 6

    Long-term metabolic follow-up and clinical outcome of 35 patients with maple syrup urine disease.

    Abi-Wardé MT, Roda C, Arnoux JB, et al.

    Journal of inherited metabolic disease 2017; (40(6)):783-792 doi:10.1007/s10545-017-0083-x.

    PMID: 28905140
  7. 7

    Maple syrup urine disease decompensation misdiagnosed as a psychotic event.

    Higashimoto T, Whitehead MT, MacLeod E, et al.

    Molecular genetics and metabolism reports 2022; (32()):100886 doi:10.1016/j.ymgmr.2022.100886.

    PMID: 35756860
  8. 8

    Clues and challenges in the diagnosis of intermittent maple syrup urine disease.

    Pode-Shakked N, Korman SH, Pode-Shakked B, et al.

    European journal of medical genetics 2020; (63(6)):103901 doi:10.1016/j.ejmg.2020.103901.

    PMID: 32151765
  9. 9

    Imaging Findings in Maple Syrup Urine Disease: A Case Report.

    Kathait AS, Puac P, Castillo M

    Journal of pediatric neurosciences 2018; (13(1)):103-105 doi:10.4103/JPN.JPN_38_17.

    PMID: 29899783
  10. 10

    MRI and clinical features of maple syrup urine disease: preliminary results in 10 cases.

    Cheng A, Han L, Feng Y, et al.

    Diagnostic and interventional radiology (Ankara, Turkey) 2017; (23(5)):398-402 doi:10.5152/dir.2017.16466.

    PMID: 28830848
  11. 11

    Pathophysiology of maple syrup urine disease: Focus on the neurotoxic role of the accumulated branched-chain amino acids and branched-chain α-keto acids.

    Amaral AU, Wajner M

    Neurochemistry international 2022; (157()):105360 doi:10.1016/j.neuint.2022.105360.

    PMID: 35577033
  12. 12

    Living with Intoxication-Type Inborn Errors of Metabolism: A Qualitative Analysis of Interviews with Paediatric Patients and Their Parents.

    Zeltner NA, Landolt MA, Baumgartner MR, et al.

    JIMD reports 2017; (31()):1-9 doi:10.1007/8904_2016_545.

    PMID: 26983835
  13. 13

    Implications of Maple Syrup Urine Disease in Newborns.

    Harris-Haman P, Brown L, Massey S, Ramamoorthy S

    Nursing for women's health 2017; (21(3)):196-206 doi:10.1016/j.nwh.2017.04.009.

    PMID: 28599741

This page is for informational purposes only and does not constitute medical advice about MSUD. Your metabolic team and other clinicians can interpret your child’s development, mental health, and need for urgent assessment.

Get notified when new evidence is published on Maple syrup urine disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.